Supplementary Material for: Prolonged survival in metastatic pancreatic acinar cell carcin

A single-case report details the treatment and molecular evolution of a rare pancreatic cancer. The document describes a 36-year-old male patient with metastatic pancreatic acinar cell carcinoma who received hepatic arterial infusion chemotherapy. The report includes longitudinal molecular profiling data showing genomic changes over the course of treatment.

Use Cases

• Study the clinical course of pancreatic acinar cell carcinoma based on the detailed patient history.
• Analyze the efficacy of hepatic arterial infusion chemotherapy for liver metastases based on the reported treatment response.
• Investigate genomic evolution in cancer under treatment pressure based on the serial molecular analyses described.
• Review the feasibility of re-biopsy and targeted trial inclusion based on the case's molecular profiling narrative.

Strengths

• Includes detailed longitudinal molecular profiling data for a single patient.
• Describes a specific treatment regimen involving approximately 60 oxaliplatin-based cycles.
• Document is published under a CC-BY-4.0 license, allowing for reuse.

Limitations

• Data is limited to a single case report, which restricts statistical analysis and generalizability.
• The dataset is a PDF document (835.3 KB); structured data extraction may be required for computational analysis.
• Column-level documentation is absent; field semantics must be inferred from the narrative text.

Provenance

Source

figshare admin karger

Collection Method

Published as supplementary material for a medical case report.

Freshness

Last updated 2026-05-14 05:55:10; freshness should be verified.